These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 26857693)
21. A European perspective on orally inhaled products: in vitro requirements for a biowaiver. García-Arieta A J Aerosol Med Pulm Drug Deliv; 2014 Dec; 27(6):419-29. PubMed ID: 25238116 [TBL] [Abstract][Full Text] [Related]
22. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size. Usmani OS; Biddiscombe MF; Barnes PJ Am J Respir Crit Care Med; 2005 Dec; 172(12):1497-504. PubMed ID: 16192448 [TBL] [Abstract][Full Text] [Related]
23. Optimisation of DMPK by the inhaled route: challenges and approaches. Cooper AE; Ferguson D; Grime K Curr Drug Metab; 2012 May; 13(4):457-73. PubMed ID: 22299825 [TBL] [Abstract][Full Text] [Related]
24. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model. Kim J; Xi J; Si X; Berlinski A; Su WC J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):209-18. PubMed ID: 23808762 [TBL] [Abstract][Full Text] [Related]
25. Insights on animal models to investigate inhalation therapy: Relevance for biotherapeutics. Guillon A; Sécher T; Dailey LA; Vecellio L; de Monte M; Si-Tahar M; Diot P; Page CP; Heuzé-Vourc'h N Int J Pharm; 2018 Jan; 536(1):116-126. PubMed ID: 29180257 [TBL] [Abstract][Full Text] [Related]
26. Using MRI to measure aerosol deposition. Thompson RB; Finlay WH J Aerosol Med Pulm Drug Deliv; 2012 Apr; 25(2):55-62. PubMed ID: 22463490 [TBL] [Abstract][Full Text] [Related]
28. Regulatory toxicology considerations for the development of inhaled pharmaceuticals. Owen K Drug Chem Toxicol; 2013 Jan; 36(1):109-18. PubMed ID: 22273711 [TBL] [Abstract][Full Text] [Related]
29. In vitro/in vivo comparisons in pulmonary drug delivery. Newman SP; Chan HK J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834 [TBL] [Abstract][Full Text] [Related]
30. Recent advances in predictive understanding of respiratory tract deposition. Finlay WH; Martin AR J Aerosol Med Pulm Drug Deliv; 2008 Jun; 21(2):189-206. PubMed ID: 18518795 [TBL] [Abstract][Full Text] [Related]
31. Clinical perspectives on pulmonary systemic and macromolecular delivery. Scheuch G; Kohlhaeufl MJ; Brand P; Siekmeier R Adv Drug Deliv Rev; 2006 Oct; 58(9-10):996-1008. PubMed ID: 16996638 [TBL] [Abstract][Full Text] [Related]
32. [Deposition of particles in the respiratory tract]. Lieutier-Colas F Allerg Immunol (Paris); 2001 Feb; 33(2):59-63. PubMed ID: 11339054 [TBL] [Abstract][Full Text] [Related]
33. The co-imaging of gamma camera measurements of aerosol deposition and respiratory anatomy. Conway J; Fleming J; Bennett M; Havelock T J Aerosol Med Pulm Drug Deliv; 2013 Jun; 26(3):123-30. PubMed ID: 23517170 [TBL] [Abstract][Full Text] [Related]
35. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Oberdorster G Inhal Toxicol; 1996; 8 Suppl():73-89. PubMed ID: 11542496 [TBL] [Abstract][Full Text] [Related]
36. Assessment methods of inhaled aerosols: technical aspects and applications. Jaafar-Maalej C; Andrieu V; Elaissari A; Fessi H Expert Opin Drug Deliv; 2009 Sep; 6(9):941-59. PubMed ID: 19637979 [TBL] [Abstract][Full Text] [Related]